focus
Previous article：
Supreme Court strikes down use of affirmative action
Next article： AstraZeneca, Daiichi breast cancer treatment succeeds in trial
Next article： AstraZeneca, Daiichi breast cancer treatment succeeds in trial
hotspot
knowledge
-
Readout Newsletter: Replicate, Biogen's Leqembi, and Humira
2025-09-02 07:39
-
Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds
2025-09-02 07:27
-
CommonSpirit Health keeps growing, even as it loses money
2025-09-02 07:22
-
Ebola vaccine can save some who are already sick, per new study
2025-09-02 07:16
-
How AI helped researchers track recovery from depression
2025-09-02 07:07
-
FDA panel to weigh approval of NurOwn, controversial ALS drug
2025-09-02 06:26